NASDAQ:RDNT RadNet (RDNT) Stock Forecast, Price & News $27.61 +0.31 (+1.14%) (As of 09/22/2023 ET) Add Compare Share Share Today's Range$27.02▼$27.8150-Day Range$27.30▼$34.9952-Week Range$12.03▼$35.18Volume323,523 shsAverage Volume548,358 shsMarket Capitalization$1.87 billionP/E RatioN/ADividend YieldN/APrice Target$33.33 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainabilityProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability RadNet MarketRank™ ForecastAnalyst RatingBuy3.00 Rating ScoreUpside/Downside20.7% Upside$33.33 Price TargetShort InterestHealthy2.46% of Shares Sold ShortDividend StrengthN/ASustainability-0.52Upright™ Environmental ScoreNews SentimentN/AInsider TradingN/AProj. Earnings Growth7.89%From $0.38 to $0.41 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.13 out of 5 starsMedical Sector458th out of 965 stocksMedical Laboratories Industry13th out of 23 stocks 2.5 Analyst's Opinion Consensus RatingRadNet has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $33.33, RadNet has a forecasted upside of 20.7% from its current price of $27.61.Amount of Analyst CoverageRadNet has only been the subject of 1 research reports in the past 90 days. Previous Next 5.0 Short Interest Percentage of Shares Shorted2.46% of the outstanding shares of RadNet have been sold short.Short Interest Ratio / Days to CoverRadNet has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in RadNet has recently decreased by 6.70%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldRadNet does not currently pay a dividend.Dividend GrowthRadNet does not have a long track record of dividend growth. Previous Next 4.6 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreRadNet has received a 72.34% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Mammography services ", "Nuclear medicine imaging services", and "MRI services" products. See details.Environmental SustainabilityThe Environmental Impact score for RadNet is -0.52. Previous Next 0.0 News and Social Media Coverage News Coverage This WeekMarketBeat has tracked 1 news article for RadNet this week, compared to 2 articles on an average week.Search InterestOnly 1 people have searched for RDNT on MarketBeat in the last 30 days. This is a decrease of -80% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added RadNet to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, RadNet insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 4.43% of the stock of RadNet is held by insiders.Percentage Held by Institutions74.84% of the stock of RadNet is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for RadNet are expected to grow by 7.89% in the coming year, from $0.38 to $0.41 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of RadNet is -110.44, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of RadNet is -110.44, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioRadNet has a P/B Ratio of 3.22. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About RadNet (NASDAQ:RDNT) StockRadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; offers picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as AI solutions for prostate cancer screening. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.Read More RDNT Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart RDNT Stock News HeadlinesSeptember 20, 2023 | finance.yahoo.comRadNet, Inc. to Present at the Sidoti & Company Fall 2023 Virtual Conference on Wednesday, September 20thSeptember 15, 2023 | americanbankingnews.comStockNews.com Upgrades RadNet (NASDAQ:RDNT) to "Hold"September 24, 2023 | Chaikin Analytics (Ad)Buy This Stock for AI Tidal Wave (not NVDA)The internet boom made more millionaires than any tech - Microsoft’s CEO says AI has even more potential. Here’s the #1 stock to buy.August 31, 2023 | finance.yahoo.comBe Wary Of RadNet (NASDAQ:RDNT) And Its Returns On CapitalAugust 24, 2023 | markets.businessinsider.comJim Cramer Says This Major Telecom Stock Is 'Horrendous'August 8, 2023 | finance.yahoo.comRadNet (RDNT) Q2 Earnings and Revenues Top EstimatesAugust 8, 2023 | benzinga.comA Preview Of RadNet's EarningsAugust 8, 2023 | finance.yahoo.comRadNet Reports Second Quarter Financial Results, with Record Quarterly Revenue and Adjusted EBITDA(1), and Updates 2023 Financial Guidance RangesSeptember 24, 2023 | Behind the Markets (Ad)[BREAKING] Pentagon to Spend Billions on "Living Missile"Air Force Magazine calls it "transformational." The Wall Street Journal calls it one of the Pentagon's "highest priorities." National Defense Magazine reports "Eye-popping budget" for it. This small company won the first contract to build them!July 31, 2023 | finance.yahoo.comRadNet, Inc. Announces the Addition of Sham Sokka and Sanjog Misra to Drive Further Growth Within its Digital Health InitiativesJuly 21, 2023 | finance.yahoo.comRadNet, Inc. Announces Date of its Second Quarter 2023 Financial Results Conference CallJuly 18, 2023 | markets.businessinsider.comJim Cramer Says 'Hats Off To Jamie Dimon': Why He's Bullish On JPMorganJuly 17, 2023 | msn.comRadNet: Growing Procedure Volumes - Significant Upside PotentialJune 16, 2023 | finance.yahoo.comRadNet Announces Closing Of Upsized Public Offering Of Common StockJune 14, 2023 | markets.businessinsider.comWhy RadNet (RDNT) Stock Is Getting HammeredJune 14, 2023 | marketwatch.comRadNet Shares Fall After Pricing Stock OfferingJune 14, 2023 | msn.comMicroVision, RadNet And Other Big Stocks Moving Lower In Wednesday's Pre-Market SessionJune 14, 2023 | msn.comRadNet shares slide on pricing upsized $225M stock offeringJune 14, 2023 | finance.yahoo.comRadNet Announces Pricing of Upsized Public Offering of Common StockJune 13, 2023 | benzinga.comRadNet shares are trading lower after the company announced a proposed $475 million underwritten public offering of common stock.June 13, 2023 | finance.yahoo.comRADNET ANNOUNCES PROPOSED $175 MILLION UNDERWRITTEN PUBLIC OFFERING OF COMMON STOCKJune 5, 2023 | finance.yahoo.comRadNet, Inc. to Present at the Jefferies 2023 Global Healthcare Conference on June 8, 2023May 24, 2023 | finance.yahoo.comAre Investors Undervaluing RadNet, Inc. (NASDAQ:RDNT) By 42%?May 13, 2023 | seekingalpha.comRadNet, Inc. (RDNT) Q1 2023 Earnings Call TranscriptMay 12, 2023 | msn.comRaymond James Maintains Radnet (RDNT) Outperform RecommendationMay 10, 2023 | markets.businessinsider.comRaymond James Keeps Their Buy Rating on Radnet (RDNT)May 9, 2023 | markets.businessinsider.comRadNet earnings: here's what Wall Street expectsSee More Headlines Receive RDNT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for RadNet and its competitors with MarketBeat's FREE daily newsletter. Email Address RDNT Company Calendar Last Earnings8/08/2023Today9/24/2023Next Earnings (Estimated)11/08/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Medical laboratories Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:RDNT CUSIPN/A CIK790526 Webwww.radnet.com Phone(310) 445-2800Fax310-445-2980Employees9,067Year Founded1980Price Target and Rating Average Stock Price Forecast$33.33 High Stock Price Forecast$40.00 Low Stock Price Forecast$30.00 Forecasted Upside/Downside+20.7%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)($0.25) Trailing P/E RatioN/A Forward P/E Ratio72.66 P/E GrowthN/ANet Income$10.65 million Net Margins-0.84% Pretax Margin1.09% Return on Equity3.98% Return on Assets0.89% Debt Debt-to-Equity Ratio1.11 Current Ratio1.39 Quick Ratio1.39 Sales & Book Value Annual Sales$1.43 billion Price / Sales1.31 Cash Flow$3.54 per share Price / Cash Flow7.80 Book Value$8.57 per share Price / Book3.22Miscellaneous Outstanding Shares67,770,000Free Float64,771,000Market Cap$1.87 billion OptionableOptionable Beta1.68 Social Links 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report Key ExecutivesDr. Howard G. Berger M.D. (Age 77)Chairman, Pres & CEO Comp: $5.56MMr. Mark D. Stolper (Age 52)Exec. VP & CFO Comp: $1.13MMr. Mital Patel (Age 37)Exec. VP of Financial Planning & Analysis and Chief Admin. Officer Comp: $1.15MMr. Norman R. Hames (Age 67)Pres & COO of Western Operations Comp: $1.28MMr. Stephen M. Forthuber (Age 62)Pres & COO of Eastern Operations Comp: $1.3MMs. Christine Nayoma Gordon (Age 60)Sr. VP of Operations - Northern California & Director Comp: $384.38kMr. Ranjan Jayanathan (Age 67)Exec. VP, Chief Information Officer & GM of eRAD - Radiology Information Technology Division Dr. Gregory Sorensen M.D. (Age 61)Exec. VP, Chief Science Officer & Director Ms. Laura Foster BSRTMPH, J.D., Sr. VP of Compliance & Regulatory AffairsMr. David Jeffrey Katz (Age 58)Exec. VP, Chief Legal Officer & Corp. Sec. More ExecutivesKey CompetitorsFortreaNASDAQ:FTREFulgent GeneticsNASDAQ:FLGTViridian TherapeuticsNASDAQ:VRDNGuardant HealthNASDAQ:GHNateraNASDAQ:NTRAView All CompetitorsInsiders & InstitutionsBarclays PLCBought 2,518 shares on 9/21/2023Ownership: 0.041%Wolverine Trading LLCBought 10,980 shares on 8/23/2023Ownership: 0.016%California State Teachers Retirement SystemBought 4,277 shares on 8/21/2023Ownership: 0.101%Teachers Retirement System of The State of KentuckyBought 855 shares on 8/21/2023Ownership: 0.023%Nuveen Asset Management LLCSold 955 shares on 8/16/2023Ownership: 0.189%View All Insider TransactionsView All Institutional Transactions RDNT Stock - Frequently Asked Questions Should I buy or sell RadNet stock right now? 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for RadNet in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" RDNT shares. View RDNT analyst ratings or view top-rated stocks. What is RadNet's stock price forecast for 2023? 3 Wall Street research analysts have issued 12 month target prices for RadNet's stock. Their RDNT share price forecasts range from $30.00 to $40.00. On average, they predict the company's share price to reach $33.33 in the next year. This suggests a possible upside of 20.7% from the stock's current price. View analysts price targets for RDNT or view top-rated stocks among Wall Street analysts. How have RDNT shares performed in 2023? RadNet's stock was trading at $18.83 at the beginning of 2023. Since then, RDNT shares have increased by 46.6% and is now trading at $27.61. View the best growth stocks for 2023 here. When is RadNet's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 8th 2023. View our RDNT earnings forecast. How were RadNet's earnings last quarter? RadNet, Inc. (NASDAQ:RDNT) posted its quarterly earnings data on Tuesday, August, 8th. The medical research company reported $0.24 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.07 by $0.17. The medical research company earned $403.70 million during the quarter, compared to analyst estimates of $389.29 million. RadNet had a negative net margin of 0.84% and a positive trailing twelve-month return on equity of 3.98%. The firm's revenue for the quarter was up 13.9% on a year-over-year basis. During the same period last year, the firm posted $0.15 earnings per share. What ETFs hold RadNet's stock? ETFs with the largest weight of RadNet (NASDAQ:RDNT) stock in their portfolio include Invesco S&P SmallCap Health Care ETF (PSCH), SPDR S&P Health Care Services ETF (XHS), Invesco Dorsey Wright Healthcare Momentum ETF (PTH) and First Trust Small Cap Growth AlphaDEX Fund (FYC).iShares U.S. Healthcare Providers ETF (IHF). What guidance has RadNet issued on next quarter's earnings? RadNet issued an update on its FY 2023 earnings guidance on Tuesday, August, 8th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $1.57 billion-$1.61 billion, compared to the consensus revenue estimate of $1.54 billion. What is Howard G. Berger's approval rating as RadNet's CEO? 174 employees have rated RadNet Chief Executive Officer Howard G. Berger on Glassdoor.com. Howard G. Berger has an approval rating of 45% among the company's employees. This puts Howard G. Berger in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of RadNet own? Based on aggregate information from My MarketBeat watchlists, some companies that other RadNet investors own include Advanced Micro Devices (AMD), AbbVie (ABBV), Inovio Pharmaceuticals (INO), NVIDIA (NVDA), OPKO Health (OPK), Boeing (BA), Rigel Pharmaceuticals (RIGL), UnitedHealth Group (UNH), Pfizer (PFE) and AT&T (T). What is RadNet's stock symbol? RadNet trades on the NASDAQ under the ticker symbol "RDNT." Who are RadNet's major shareholders? RadNet's stock is owned by a variety of retail and institutional investors. Top institutional investors include BlackRock Inc. (13.80%), Beck Mack & Oliver LLC (5.59%), Point72 Asset Management L.P. (3.05%), State Street Corp (2.97%), Dimensional Fund Advisors LP (2.74%) and Global Alpha Capital Management Ltd. (2.63%). Insiders that own company stock include Christine Nayoma Gordon, David L Swartz, John V Crues, Lawrence L Levitt, Lawrence L Levitt, Michael N Murdock, Norman R Hames and Ruth Louisa Villigerwilson. View institutional ownership trends. How do I buy shares of RadNet? Shares of RDNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is RadNet's stock price today? One share of RDNT stock can currently be purchased for approximately $27.61. How much money does RadNet make? RadNet (NASDAQ:RDNT) has a market capitalization of $1.87 billion and generates $1.43 billion in revenue each year. The medical research company earns $10.65 million in net income (profit) each year or ($0.25) on an earnings per share basis. How many employees does RadNet have? The company employs 9,067 workers across the globe. How can I contact RadNet? RadNet's mailing address is 1510 COTNER AVE, LOS ANGELES CA, 90025. The official website for the company is www.radnet.com. The medical research company can be reached via phone at (310) 445-2800, via email at investorrelations@radnet.com, or via fax at 310-445-2980. This page (NASDAQ:RDNT) was last updated on 9/24/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RadNet, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.